Cargando…

Expression of recombinant human coagulation factors VII (rFVII) and IX (rFIX) in various cell types, glycosylation analysis, and pharmacokinetic comparison

Detalles Bibliográficos
Autores principales:	Böhm, Ernst, Dockal, Michael, Graninger, Michael, Hasslacher, Meinhard, Kaliwoda, Martin, Konetschny, Christian, Mitterer, Artur, Muchitsch, Eva-Maria, Reiter, Manfred, Scheiflinger, Friedrich
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3284992/ https://www.ncbi.nlm.nih.gov/pubmed/22373195 http://dx.doi.org/10.1186/1753-6561-5-S8-P23

Ejemplares similares

Differences in N-glycosylation of recombinant human coagulation factor VII derived from BHK, CHO, and HEK293 cells
por: Böhm, Ernst, et al.
Publicado: (2015)

Real-Life Pharmacokinetics of rFVIII-Fc and rFIX-Fc
por: Traets, Marissa J.M., et al.
Publicado: (2020)

Thrombin generation potential in the presence of concizumab and rFVIIa, APCC, rFVIII, or rFIX: In vitro and ex vivo analyses
por: Kjalke, Marianne, et al.
Publicado: (2021)

Extended half‐life rFIX in major surgery—How to improve clinical practice: An intraindividual comparison
por: Valeri, Federica, et al.
Publicado: (2020)

Conformational Changes of Congenital FVII Variants with Defective Binding to Tissue Factor ARG304GLN (FVII Padua), ARG 304TRP (FVII Nagoya) and ARG79GLN (FVII Shinjo or Tondabayashi)
por: Cristiani, Andrea, et al.
Publicado: (2013)

The influence of Erythropoietin on platelet activation, thrombin generation and FVII/active FVII in patients with AMI
por: Demetz, Gabriele, et al.
Publicado: (2014)

A multicenter, observational study to evaluate hemostasis following recombinant activated FVII treatment in patients in Japan with congenital factor VII deficiency
por: Seita, Ikuo, et al.
Publicado: (2023)

The effect of the chemical chaperone 4-phenylbutyrate on secretion and activity of the p.Q160R missense variant of coagulation factor FVII
por: Andersen, Elisabeth, et al.
Publicado: (2019)

Molecular Genetic Analysis of Russian Patients with Coagulation Factor FVII Deficiency
por: Pshenichnikova, Olesya, et al.
Publicado: (2023)

Renal thromboembolism during treatment with recombinant activated factor VII (rFVIIa) in a child with hemophilia B with factor IX inhibitors
por: Milošević, Danko, et al.
Publicado: (2014)

Discharged. Not Where to Lay His Head: Chapters VII, VIII, IX
por: Fleming, George
Publicado: (1886)

Carbonic anhydrase enzymes II, VII, IX and XII in colorectal carcinomas
por: Viikilä, Pia, et al.
Publicado: (2016)

Tissue Factor/Factor FVII Complex Inhibitors in Cardiovascular Disease. Are Things Going Well?
por: Petrillo, Gianluca, et al.
Publicado: (2010)

Adipocytes express tissue factor and FVII and are procoagulant in a TF/FVIIa-dependent manner
por: Edén, Desirée, et al.
Publicado: (2019)

PB2660: HEREDITARY COAGULATION FACTOR FVII DEFICIENCY CAUSED BY COMPOUND HETEROZYGOUS MUTATIONS
por: Zhou, Rongfu, et al.
Publicado: (2023)

A case-report of the unprovoked thrombotic event in a patient with thymoma and severe FVII deficiency
por: Li, Lei, et al.
Publicado: (2023)

Benzamide-4-Sulfonamides Are Effective Human Carbonic Anhydrase I, II, VII, and IX Inhibitors
por: Abdoli, Morteza, et al.
Publicado: (2018)

Coagulation factors II, V, VII, IX, X and XI and mortality – a cohort study
por: Yap, Eng Soo, et al.
Publicado: (2023)

Vitamin K-Dependent Coagulation Factors That May be Responsible for Both Bleeding and Thrombosis (FII, FVII, and FIX)
por: Girolami, Antonio, et al.
Publicado: (2018)

Discovery of novel 1,3-diaryltriazene sulfonamides as carbonic anhydrase I, II, VII, and IX inhibitors
por: Akocak, Suleyman, et al.
Publicado: (2018)

Efficient generation of FVII gene knockout mice using CRISPR/Cas9 nuclease and truncated guided RNAs
por: An, Liyou, et al.
Publicado: (2016)

Intramuscular Expression of Plasmid-Encoded FVII-Fc Immunoconjugate for Tumor Immunotherapy by Targeting Tumoral Blood Vessels and Cells
por: Ma, Liping, et al.
Publicado: (2021)

Activated Factor XI is Increased in Plasma in Response to Surgical Trauma but not to Recombinant Activated FVII-Induced Thrombin Formation
por: Rühl, Heiko, et al.
Publicado: (2022)

Development of Methods for the Selective Measurement of the Single Amino Acid Exchange Variant Coagulation Factor IX Padua
por: Weber, Alfred, et al.
Publicado: (2018)

Synthesis and biological evaluation of histamine Schiff bases as carbonic anhydrase I, II, IV, VII, and IX activators
por: Akocak, Suleyman, et al.
Publicado: (2017)

Coagulation factors VII, IX and X are effective antibacterial proteins against drug-resistant Gram-negative bacteria
por: Chen, Jinwu, et al.
Publicado: (2019)

AAV-mediated gene transfer in the perinatal period results in expression of FVII at levels that protect against fatal spontaneous hemorrhage
por: Binny, Christopher, et al.
Publicado: (2012)

The superior role of coagulation factor FX over FVII in adenoviral-mediated innate immune induction of the hepatocyte: an in vitro experiment
por: Ghahestani, Saeed Firoozi, et al.
Publicado: (2020)

Enhanced Factor IX Activity following Administration of AAV5-R338L “Padua” Factor IX versus AAV5 WT Human Factor IX in NHPs
por: Spronck, Elisabeth A., et al.
Publicado: (2019)

Selective adaptation of German /r/: A role for perceptual saliency
por: Mitterer, Holger, et al.
Publicado: (2022)

Expanding the Versatility of Phage Display II: Improved Affinity Selection of Folded Domains on Protein VII and IX of the Filamentous Phage
por: Løset, Geir Åge, et al.
Publicado: (2011)

Identification of genetic defects underlying FVII deficiency in 10 patients belonging to eight unrelated families of the North provinces from Tunisia
por: Elmahmoudi, Hejer, et al.
Publicado: (2012)

Recombinant activated factor VII (rFVIIa) as salvage treatment for intractable hemorrhage
por: Aggarwal, Anita, et al.
Publicado: (2004)

Sustained high trough factor IX activity levels with continued use of rIX‐FP in adult and paediatric patients with haemophilia B
por: Gill, Joan C., et al.
Publicado: (2019)

Systemic antithrombotic effects of ADAMTS13
por: Chauhan, Anil K., et al.
Publicado: (2006)

Studying the Expression Efficiencies of Human Clotting Factor IX Analogs, Rationally-designed for Hyper-glycosylation
por: Ghasemi, Fahimeh, et al.
Publicado: (2021)

automRm: An R Package for Fully Automatic LC-QQQ-MS Data Preprocessing Powered by Machine Learning
por: Eilertz, Daniel, et al.
Publicado: (2022)

Phenotypical variability in congenital FVII deficiency follows the ISTH-SSC severity classification guidelines: a review with illustrative examples from the clinic
por: Jain, Shilpa, et al.
Publicado: (2018)

Extensive genetic screening of Iranian Factor FVII-deficient individuals unraveled several novel mutations and postulated founder effects in some cases
por: Ravanbod, Shirin, et al.
Publicado: (2022)

N-glycosylation of mouse TRAIL-R and human TRAIL-R1 enhances TRAIL-induced death
por: Dufour, Florent, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_47sd8jdn7kk4j78g7bre233mfo